T2 Biosystems, Inc. Marketable Securities, Gain (Loss)
T2 Biosystems, Inc. reported Marketable Securities, Gain (Loss) of $7.00 thousand for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-13.
Discontinued › Income Statement › Other Income
us-gaap:MarketableSecuritiesGainLoss · last filed 2021-05-13
- T2 Biosystems, Inc. marketable securities, gain (loss) for the quarter ending 2021-03-31 was $7.00K.
- T2 Biosystems, Inc. marketable securities, gain (loss) for fiscal 2020 was $9.00K.
| Period end | Marketable Securities, Gain (Loss) 3 month | Marketable Securities, Gain (Loss) 12 month |
|---|---|---|
| 2021-03-31 | $7.00K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $9.00K 10-K · filed 2021-03-31 |